Increasing numbers of clinical isolates of Enterobacteriaceae that produce carbapenemase are now being detected, with the most common carbapenemase found among Enterobacteriaceae in Japan being IMP-1-type metallo-b-lactamase. Clinical isolates of Enterobacteriaceae harbouring carbapenemases may be resistant to carbapenem antimicrobial agents, despite apparent in vitro susceptibility when tested according to Clinical and Laboratory Standards Institute criteria. We evaluated the prevalence of carbapenemase producers among isolates of Enterobacteriaceae at our hospital and assessed the performance of the modified Hodge test (MHT) for correctly identifying the phenotype. We studied 47 clinical isolates obtained between 2006 and 2010 for which the MIC of imipenem was 2 or 4 mg imipenem ml 21 . Antibacterial susceptibility testing was done for cephalosporins and carbapenems, the MHT was performed with meropenem and detection of the genes encoding IMP-1, VIM-2, KPC-2 and NDM-1-type metallo-b-lactamases was performed by PCR. Twelve isolates showed a positive result in the MHT with meropenem and were classified as carbapenemase producers. Of these 12 isolates, seven carried the gene for IMP-1 type, but not for VIM-2, KPC-2 or NDM-1 types. None of the carbapenemase genes tested were detected in the other five isolates. All five isolates were Enterobacter cloacae showing high resistance to ceftazidime and aztreonam. False-positive results were inhibited when Mueller-Hinton agar supplemented with 200 mg cloxacillin ml 21 was used for the MHT. Five of 12 MHT-positive isolates were shown to have no carbapenemase genes and these isolates were high AmpC producers. Adding cloxacillin when performing the MHT prevented such false-positive results. The MHT with cloxacillin can overcome most problems related to detection of carbapenemases.
INTRODUCTION
Bacterial resistance mediated by b-lactamase is increasingly associated with plasmid-encoded carbapenemases, including the Klebsiella pneumonia carbapenemase (KPC) family of serine carbapenemases (mainly in the USA), as well as Verona integron-encoded metallo-b-lactamase (VIM) (mainly in the Mediterranean region), imipenemase metallo-blactamase (IMP)-1 (mainly in Asia, including Japan) and New Delhi metallo-b-lactamase (NDM)-1 and oxacillinase (OXA)-48 (metallo-b-lactamase carbapenemases that are now endemic or rare) (Oteo et al., 2014) . However, carbapenemase-producing Enterobacteriaceae may have imipenem MICs as low as 0.125 mg imipenem ml 21 (Psichogiou et al., 2008) .
This suggests that several carbapenem screening tests may be needed to identify all strains requiring confirmation. Also, resistance of Enterobacteriaceae to b-lactams and other antibiotics is frequently associated with plasmid-mediated resistance determinants that are easily transferred among species.
The modified Hodge test (MHT) (http://www.cdc.gov/hai/) can detect carbapenemase production in isolates of Enterobacteriaceae. The Clinical and Laboratory Standards Institute (CLSI) has recommended that carbapenemsusceptible Enterobacteriaceae with elevated MICs or reduced disc diffusion inhibition zones should be tested for production of carbapenemases (CLSI, 2009) . However, some isolates show a slight indentation in the MHT, but do not produce carbapenemase (Carvalhaes et al., 2010; Thomson, 2010; Giske et al., 2011) . In this study, we evaluated the performance of the MHT for correctly identifying carbapenemase production by Enterobacteriaceae.
METHODS
Bacterial Strains. We studied 47 clinical isolates for which the MIC of imipenem was 2 or 4 mg imipenem ml 21 (43 strains of Enterobacter cloacae, three of Escherichia coli and one of Klebsiella pneumoniae). These isolates were collected at the Laboratory of Kitasato University Hospital (Kanagawa, Japan) between January 2006 and August 2010.
Susceptibility testing. We remeasured the MICs of imipenem, ceftazidime and aztreonum using the agar dilution method specified by the CLSI (CLSI, 2012) . A microplanter for MIC measurement (Sakuma Seisakusho) was used for inoculation, followed by culture for 20 h at 35 uC. Imipenem, ceftazidime and aztreonum were purchased from Sigma-Aldrich.
MHT for detection of carbapenemase. The MHT was carried out on all isolates as recommended by the CLSI (CLSI, 2012) . A meropenem disc was placed on an agar plate seeded with E. coli ATCC 25922. Isolates were then inoculated in a straight line from the edge of the disc to the edge of the plate and the plates were incubated at 35 uC for 20 h. In this test, carbapenemase production was detected when the test isolate produced the enzyme causing a characteristic cloverleaf-like indentation of E. coli ATCC 25922 growth towards the meropenem disc.
Detection and sequencing of carbapenemases genes. PCR was performed to detect the following carbapenemase genes: IMP-1, VIM-2, KPC-2 and NDM-1 types. PCR targeting the genes encoding IMP-1 and VIM-2 was done using primers described previously (Shibata et al., 2003) . PCR for KPC-2 (primers: 59-gctggacacacccatccgtt-39 and 59-gtgcagagcccagtgtcagt-39) and for NDM-1 (primers: 59-accgcccagatcctcaactg-39 and 59-cgagattgccgagcgacttg-39) involved denaturation at 94 uC for 1 min, annealing at 68 uC for 1 min and extension at 72 uC for 1 min. Both strands of the PCR products were sequenced using an ABI3730xl Analyser (Applied Biosystems).
Detection of AmpC. The acidimetric beta-lactamase assay was performed using the P/Case Test (Nissui Pharmaceutical) to detect AmpC (cephalosporinase) production by the isolates (Kawakami et al., 2000) . According to the manufacturer's instructions, colonies were spread on two indicator discs containing benzylpenicillin and cephaloridine with clavulanic acid, respectively. AmpC production caused the disc containing cephaloridine with clavulanic acid to turn yellow.
RESULTS
The susceptibility rates for imipenem, ceftazidime and aztreonum were 70.2% (33/47), 66.0% (31/47) and 83.0% (39/47), respectively (data not shown). Twelve of the 47 isolates (25.5%) were classified as carbapenemase producers based on a positive MHT with meropenem. Among these 12 isolates with a positive MHT, PCR detected the gene for IMP-1 in seven isolates (58.3%), but not genes for VIM-2, KPC-2 or NDM-1. None of the carbapenemase genes tested were detected in the other five isolates (41.7%) ( Table 1) . The five isolates that tested negative for carbapenemase genes were found to be high-level AmpC producers with a strongly positive P/Case test result and were highly resistant to aztreonum. These isolates were then retested using a MHT method that was unaffected by AmpC b-lactamases, which involved adding 200 mg cloxacillin ml 21 (an AmpC inhibitor) to the culture medium. When we compared the common MHT to this revised MHT, we found that adding cloxacillin inhibited indentation by a high-level AmpC-producing strain without any carbapenemase genes (Fig. 1a, b ), but not a strain bearing the IMP-type carbapenemase gene (Fig. 1c, d ). Among the 12 strains that were positive in the common MHT, five strains (E. cloacae KY842, 825, 867, 855 and 856) that did not possess carbapenemase genes were negative in the revised MHT with 200 mg cloxacillin ml 21 , while the remaining seven strains with IMP-1 genes were still positive in the revised MHT. Thus, false-positive results induced by high-level AmpC production could be corrected by performing the MHT with cloxacillin.
DISCUSSION
Currently, the breakpoints for carbapenems have been lowered in the US (CLSI) and European (The European Committee on Antimicrobial Susceptibility Testing: EUCAST) standards to permit better detection of carbapenem-resistant isolates. According to the CLSI (2012), the breakpoints of imipenem and meropenem are j1 for susceptible and i4 mg ml 21 for resistant, while EUCAST still defines imipenem susceptibility as up to 2 mg imipenem ml 21 (EUCAST, 2015). In our study, the MIC of imipenem was i2 mg ml 21 for 14 strains, but IPM-1, VIM-2, KPC-2 and NDM-1 were not detected in eight of these. Therefore, detection of carbapenemase producers based only on MIC values may lack sensitivity. Twelve strains with a positive MHT all showed ceftazidime resistance (Table 1) . For this reason, ceftazidime is used for daily examination of Enterobacteriaceae and can be suitable for screening MBL-producing strains. Cloxacillin is a cephalosporinase inhibitor that can be used to prevent growth of Enterobacteriaceae isolates with high expression of cephalosporinases (Carvalhaes et al., 2010) .
As shown in Fig. 1 , inhibition of AmpC activity by plating test strains on cloxacillin-containing agar allowed differentiation between strains that would recover susceptibility to carbapenems and those exhibiting low-level carbapenem resistance owing to carbapenemase production. Moland Meropenem discs supplemented with dipicolinic acid, EDTA, aminophenylboronic acid, CHROMagar KPC and chromID CARBA medium (Samra et al., 2008; Giske et al., 2011; Papadimitriou-Olivgeris et al., 2014) would be able to discriminate among Enterobacteriaceae with various carbapenemases. Recent studies have assessed the frequency of falsely detecting carbapenemase production in Enterobacteriaceae with the MHT in the routine clinical microbiology setting by employing zinc sulfate (SUPERCARBA medium) (Nordmann et al., 2012) and the CarbaNP test (Vasoo et al., 2013) . Mathers et al. (2013) demonstrated the indirect carbapenemase test was superior to the MHT for non-Klebsiella Enterobacteriaceae. Galani et al. (2008) highlighted one limitation of the MHT, which is that imipenem-susceptible isolates with a positive MHT that are negative by all other methods produce AmpC from chromosomal or plasmid-encoded genes. Therefore, equivocal MHT isolates must be confirmed by another method. There have been a few published surveys on the detection of KPC and metallo-b-lactamase carbapenemase in Enterobacteriaceae using meropenem discs supplemented with cloxacillin (Giske et al., 2011; Pasteran et al., 2011) , but none of these reports covered the MHT using agar supplemented with cloxacillin. Therefore, our method is the first to be used for detection of carbapenemase production by Enterobacteriaceae which is not influenced by AmpC.
In conclusion, the common MHT can incorrectly report a positive result for carbapenemase production by Enterobacteriaceae, possibly due to high AmpC production. PCR-based techniques remain the reference standard for identification and differentiation of carbapenemases, but have the disadvantages of higher cost and the requirement for trained technicians. Detecting carbapenemases by the revised MHT with cloxacillin is a rapid and cost-effective test that can identify resistant pathogens in any laboratory.
